Oxford University's 'Vaccine for the World' is Effective


'Vaccine for the World'

The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.

Tags: AstraZeneca, covid-19, health and medical, Oxford University, vaccine

Featured Videos